HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Yukio Okazaki Masafumi Natsuaki Tsuyoshi Itoh Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Cao, Z.-L. Articles by Itoh, T. Search for Related Content PubMed PubMed Citation Articles by Cao, Z.-L. Articles by Itoh, T.

Ann Thorac Surg 2000;69:1121-1126
© 2000 The Society of Thoracic Surgeons

---

ORIGINAL ARTICLES: CARDIOVASCULAR

Ulinastatin attenuates reperfusion injury in the isolated blood-perfused rabbit heart

^a Department of Thoracic and Cardiovascular Surgery, Saga Medical School, Saga, Japan

Address reprint requests to Dr Itoh, Department of Thoracic and Cardiovascular Surgery, Saga Medical School, 5-1-1 Nabeshima, Saga City, Saga 849-8501, Japan
e-mail: itoht2{at}post.saga-med.ac.jp

Background. Ventricular dysfunction after long cardioplegic arrest has been observed in cardiac operations. Urinary trypsin inhibitor, also called ulinastatin, may attenuate myocardial ischemia-reperfusion injury. The present study was designed to determine the protective efficacy of ulinastatin in blood-perfused parabiotic isolated rabbit hearts as a surgically relevant model with long (4-hour) cardioplegic arrest.

Methods. Each isolated rabbit heart, with a latex balloon inserted in the left ventricle, was parabiotically blood-perfused using a modified Langendorff column. The left ventricular developed pressure, rate of pressure development, and coronary flow with a left ventricular end-diastolic pressure of 10 mmHg were measured before ischemia and 15, 30, 45, and 60 minutes after reperfusion began (control, n = 10). Ulinastatin (15,000 U/kg) was administered to the support animal just before reperfusion began (group U-1, n = 10) or at the beginning of the extracorporeal circulation and readministered before reperfusion (group U-2, n = 10). The endothelium of the coronary artery was observed by scanning electron microscopy to evaluate the extent of endothelial ischemia-reperfusion injury.

Results. Ulinastatin enhanced the recovery of developed pressure in both the U-1 (p < 0.05) and U-2 (p < 0.01) groups compared with the control group. Although ulinastatin given just before reperfusion (group U-1) did not enhance the recovery of the rate of pressure development or the coronary flow compared with the control, earlier administration did improve the recovery of the rate of pressure development compared with the control (U-2, p < 0.05), and there was improvement of the recovery of coronary flow after 60 minutes of reperfusion (U-2, p < 0.05). Scanning electron microscopy showed that ulinastatin had ameliorated coronary endothelial damage.

Conclusions. Ulinastatin improved functional recovery after long cardioplegic arrest and reduced coronary endothelial injury. Administration of ulinastatin at the beginning of cardiopulmonary bypass and just before reperfusion may be useful clinically in cases requiring prolonged aortic cross-clamping.

This article has been cited by other articles:

				K. Takarabe, Y. Okazaki, S. Higuchi, J. Murayama, M. Natsuaki, and T. Itoh Nicorandil Attenuates Reperfusion Injury after Long Cardioplegic Arrest Asian Cardiovasc Thorac Ann, June 1, 2007; 15(3): 204 - 209. [Abstract] [Full Text] [PDF]